# Effectiveness of the Combination Strategy of Disease-Modifying Therapy and the Yishen Daluo Yin Modified Formula for Multiple Sclerosis

> **NCT07037823** · — · NOT_YET_RECRUITING · sponsor: **Ying Gao** · enrollment: 328 (estimated)

## Conditions studied

- RRMS

## Interventions

- **OTHER:** Modified Yishen Daluo Yin formula

## Key facts

- **NCT ID:** NCT07037823
- **Lead sponsor:** Ying Gao
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2026-10-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 328 (ESTIMATED)
- **Last updated:** 2025-06-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07037823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07037823, "Effectiveness of the Combination Strategy of Disease-Modifying Therapy and the Yishen Daluo Yin Modified Formula for Multiple Sclerosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07037823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*